Investing.com — 周五，Cantor Fitzgerald重申了对Centene Corporation (NYSE: CNC )的增持评级，维持90.00美元的目标价。该公司分析师Sarah James强调，尽管政策风险可能影响公司业绩，但Centene仍有盈利增长潜力。这一观点与 InvestingPro ...

Moonlake Immunotherapeutics对HS市场的关注得到了当前处方趋势和Bimzelx在银屑病治疗方面地位增强的支持。Cantor Fitzgerald的"增持"评级表明对公司股票表现和产品最新发展带来的潜在市场机会充满信心。下一次财报预计于2025年5月8日发布，投资者可通过 InvestingPro 获取超过1,400只美国股票的详细研究报告，深入了解更多信息和专业提示。

We recently published a list of 10 Firms Take a Beating on Tariff Worries. In this article, we are going to take a look at ...

Two days after US President Donald Trump announced reciprocal tariffs on almost all countries, including American allies, ...

National Bank Financial analyst John Shao, who has an “outperform” (similar to buy) and $22 on the stock, said the stock sell ...

Research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of Bradmer Pharmaceuticals in a note issued to investors on Monday, March 31st. Cantor Fitzgerald analyst B.

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Buy” from the ...

Wall Street’s three major indices suffered a bloodbath on Thursday as investors continued to digest news of President Donald Trump’s tariff rollout on imports. The tech-heavy Nasdaq fell the heaviest, ...

Trump's cabinet of billionaires and mere millionaires all took hits in the stock market Thursday as Trump's 'reciprocal' tariffs spooked investors and invited fears of a global recession.

Fintel reports that on April 3, 2025, Cantor Fitzgerald upgraded their outlook for Zscaler (NasdaqGS:ZS) from Neutral to ...

The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...

The European Union won’t take chicken from America. They won’t take lobsters from America. They hate our beef because our ...